Conversely, it was reported in the context of type II diabetes and fatty liver disease that increased phosphorylation of AKT was an indicator of insulin response and consequently a good prognostic marker for reduced steatosis (Vivero et al, 2021). This evidence concerns the gene AKT1 and steatosis.